Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Michael S Brown
Michael S Brown is Director at Regeneron Pharmaceuticals. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jan 6, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.